The vast majority of health care in Australia leads to good health outcomes. However, patients do not always receive the most appropriate care and preventable adverse events can occur. The issue of patient safety has been recognised as both a
Leading drug developers publish insights in three prestigious international journals.
A team of international researchers including experts from Certara, the
The Monash Faculty of Pharmacy and Pharmaceutical Sciences has launched a new website aimed at capturing the wide variety of contributions that
Monash University researchers develop new international consensus principles for medicines management in frail older people
Researchers from the Centre for Medicine Use and Safety (CMUS) at the Monash Institute of Pharmaceutical Sciences (MIPS) and the National Health and Medical Research Council Centre of Research Excellence(CRE) in Frailty and Healthy Ageing have
Simple works best: Monash University study finds a way to reduce medicine risk for older Australians
Almost one million Australians aged 70+ are regularly taking five or more prescription medicines. The Royal Commission on Aged Care Quality and Safety has highlighted complex medication regimens as a risk to the health and safety of older people.
Australian researchers use big data to advance studies and optimise prescribing for those living with neurological and mental health conditions
Researchers from around the globe have joined forces to create the world’s first international ‘big data’ platform, designed specifically to tackle medication use and outcomes in people living with neurological and mental health
International study reaffirms cardiovascular benefits associated with medication used to treat type 2 diabetes
A large-scale international study published in prestigious journal The Lancet, Diabetes & Endocrinology, has provided further support for
Up to two thirds of people with dementia are prescribed potentially inappropriate medications, with a new study from Monash University exploring system challenges which may lead to this.
New research from Monash University, in collaboration with the University of North Carolina at Chapel Hill, could change the way patients with life-threatening drug-resistant infections across the world are treated.